Intramuscular artemether in treatment of severe Malaria: Current results;L'artemether intra-musculaire dans le traitement des paludismes graves: Synthese des resultats actuels

Medecine Tropicale

Volumn 57, Issue 3, 1997, Pages 289-293

  Ambroise Thomas, P ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Artemether; Clinical trials; Malaria; Qinghaosu

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; QUININE; SESQUITERPENE;

ADULT; CHILD; DRUG RESISTANCE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; METHODOLOGY; PARASITOLOGY; REVIEW; SURVIVAL; TREATMENT OUTCOME;

ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; DRUG RESISTANCE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MALARIA; QUININE; RESEARCH DESIGN; SESQUITERPENES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0000697140     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. JELINEK T., SCHELBERT P., LOSCHER T., EICHENLAUB D. - Quinine resistant falciparum malaria acquired in East Africa. Trop Med. Parasitol. 1995 ; 46 : 38-40.
2. AMBROISE-THOMAS P. - La place des dérivés du Qinghao dans le traitement du paludisme en 1995. Med. Trop. 1995 ; 55 Suppl. 1 : 18-20.
3. HIEN T.T., WHITE N.J. - Qinghaosu. Lancet 1993 ; 341 : 603-608.
4. CAVERO I., FLOCH A., GUILLON M.C. et Coll. - Favourable profile of artemether in safety pharmacological studies. Jpn. J. Trop. Med Hyg. 1996 ; 24 Suppl. 1 : 79-86.
5. AMBROISE-THOMAS P. - Overview of the results obtained with IM artemether in the treatment of severe falciparum malaria. Jpn. J. Trop. Med. Hyg. 1996 ; 24 Suppl. 1 : 87-91.
6. EKOBO S., WAMBA G., NGOGANG J., EYENGA N. - Efficacité et tolérance de l'artéméther dans le traitement des accès palustres graves à Plasmodium falciparum à Yaoundé. Objectif Médical Magazine 1994 ; 7 : 25-30.
7. KONE M., PENALI L., HOUENOU Y., NIANGO J-P. - Traitement de l'accès palustre à Plasmodium falciparum par artéméther. Med. Afr. Noire 1994 ; 41 : 729-735.
8. KARBWANG J., TIN T., RIMCHALA W. et Coll. - Comparison of artemether and quinine in the treatment of severe falciparum malaria in South-East Thailand. Trans. R. Soc. Trop. Med. Hyg. 1995 ; 89: 668-671.
9. TINH HIEN T., DAY N.P.J., HOAN PHU N. et Coll. - A controlled trial of artemether and quinine in Vietnamese adults with severe falciparum malaria. N. Engl. J. Med. 1996 ; 335 : 76-83.
10. WIN K., MALARIAR T., THWE Y. et Coll. - Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Bull. WHO 1992 ; 70 : 777-782.
11. MYIN P.T., SHWE T. - The efficacy of artemether (Qinghaosu) in Plasmodium falciparum and Plasmodium vivax in Burma. Southeast Asian J. Trop. Public Health 1986 ; 17 : 19-22.
12. MYIN P.T., SHWE T. - A controlled clinical trial of artemether (Qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1987 ; 81 : 559-561.
13. SHWE T., MYLN P.T. HTUT Y. et Coll. - The effect of mefloquineartemether compared with quinine on patients with complicated falciparum malaria. Trans. R Soc. Trop. Med. Hyg. 1988 ; 82 : 665-666.
14. ELHASSAN I.M., SATTI G.H.M., ALI A.E. et Coll. - The efficacy of artemether in the treatment of Plasmodium falciparum malaria in Sudan. Trans. R. Soc. Trop. Med. Hyg. 1993 ; 87 : 685-686.
15. DANIS M., CHANDENIER J., DOUMBO O. et Coll. - Results obtained with IM artemether versus IV quinine in the treatment of severe malaria in a multicentre study in Africa. Jpn. J. Trop. Med. Hyg. 1996 ; 24 Suppl. 1 : 93-96.
16. BOELE VAN HENSBROEK M., ONYIORAH E., JAFFAR S. et Coll. - A trial of artemether or quinine in children with cerebral malaria. N. Engl. J. Med. 1996 ; 335 . 69-75
17. TAYLOR T.E., WILLS B.A., KAZEMBE P. et Coll - Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet 1993 ; 341 : 661-662.
18. WORLD HEALTH ORGANIZATION - Essential drugs. WHO model list revised in December 1995. In «WHO drug information» WHO ed., Geneva, 1995. pp 223-234.